Items Tagged ‘Merck & Co.’

June 12, 2012

J&J Diabetes Drug Seen Challenging Merck’s Market Leader


The spotlight is now on J&J’s canagliflozin, which is designed to expel excess sugar from the body, something that doesn’t normally occur until after glucose rises to critical levels. The pill may reach pharmacies next year, competing with Merck & Co.’s $3.3 billion market leader Januvia…“Using a side effect of uncontrolled diabetes as a primary […]

View full entry

Tags: Bloomberg, canagliflozin, Dr. Adrian Vella, Januvia, Merck & Co.

Contact Us · Privacy Policy